GASTRIC (STOMACH) CANCER
Clinical trials for GASTRIC (STOMACH) CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTRIC (STOMACH) CANCER trials appear
Sign up with your email to follow new studies for GASTRIC (STOMACH) CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink stomach tumors
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding pucotenlimab and lenvatinib to standard chemotherapy (SOX) helps shrink tumors more than chemotherapy alone in people with advanced HER2-negative stomach or gastroesophageal junction cancer. About 100 adults aged 18-75 who have not had prior treatm…
Matched conditions: GASTRIC (STOMACH) CANCER
Phase: EARLY_PHASE1 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Engineered immune cells take on multiple Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a personalized cell therapy (ADP-A2M4CD8) for people with advanced cancers like lung, ovarian, or melanoma that have a specific marker called MAGE-A4. The treatment uses the patient's own immune cells, modified to better attack the cancer, and is give…
Matched conditions: GASTRIC (STOMACH) CANCER
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Stool test could spot stomach cancer before it spreads
Diagnosis OngoingThis study looks at whether testing stool samples for certain DNA changes and bacteria can help detect stomach cancer early. Researchers will follow 3000 people, including those with and without cancer, to see how well the test works. The goal is to create a simple, non-invasive …
Matched conditions: GASTRIC (STOMACH) CANCER
Sponsor: Fudan University • Aim: Diagnosis
Last updated May 22, 2026 14:02 UTC